Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Schering describes histamine H3 antagonists for use in allergic rhinitis

June 14, 2002

Sheffield completes phase I studies of NanoCrystal Budesonide product

June 13, 2002

Byk files for approval of ciclesonide for asthma in Canada

June 13, 2002

Corus enters licensing deal with BattellePharma for asthma drug delivery technology

June 13, 2002

Potential therapeutic benefit of inhibitors of the MAPK pathway in lung diseases

June 10, 2002

New indications approved for desloratadine in E.U.

June 7, 2002

Effects of mepolizumab on allergen-induced late-phase skin reaction studied in atopic asthmatics

June 7, 2002

New CCR3 antagonists in the Novartis pipeline

June 7, 2002

Naples presentations include new clinical data for ciclesonide in asthma patients

June 6, 2002

Intranasal and oral MOL-6131 reduces antigen-induced airways inflammation

June 6, 2002

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...